Qizhizhi data shows that Ankang (Shanghai) Biotechnology Co., Ltd. was established on March 16, 2018, with a registered capital of 20 million yuan and 20 insured persons. It is a company engaged in research and experimental development, pharmaceuticals A national high-tech enterprise focusing on manufacturing. The company has been awarded qualifications and honors such as "Innovative Small and Medium-sized Enterprises" and "National Science and Technology Small and Medium-sized Enterprises".

In terms of intellectual property rights, Ankang (Shanghai) Biotechnology Co., Ltd. has 3 registered trademarks, 17 software copyrights, and 4 patent information. In addition, Ankang (Shanghai) Biotechnology Co., Ltd. also directly controls one company.